Biora Therapeutics, Inc. (BIOR) Misses Q1 EPS by 152c

Biora Therapeutics, Inc. (NASDAQ: BIOR) reported Q1 EPS of ($1.59), $1.52 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Biora Therapeutics, Inc. (BIOR) click here.

You May Also Be Interested In

• Dell’s earning report was bullish for Intel CPU demand, analyst says
• StoneX on Mama’s Creations (MAMA): 'We Remain High-Conviction Buyers'
• TSX movers: VersaBank jumps 10% as corporate catalysts lift top gainers